ImmunoGen Quarterly Balance Sheets Chart
Quarterly
|
Annual
ImmunoGen Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2014-09-30 | 2013-12-31 | 2013-09-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2011-09-30 | 2010-12-31 | 2010-09-30 | 2010-03-31 | 2009-12-31 | 2009-09-30 | 2008-09-30 | 2007-12-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-12-31 | 2006-09-30 | 2006-06-30 | 2006-03-31 | 2005-12-31 | 2005-09-30 | 2005-06-30 | 2005-03-31 | 2004-12-31 | 2004-09-30 | 2004-03-31 | 2003-12-31 | 2003-09-30 | 2003-03-31 | 2002-12-31 | 2002-09-30 | 2002-03-31 | 2001-12-31 | 2001-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| cash and cash equivalents | 605,535,000 | 571,987,000 | 201,249,000 | 275,138,000 | 309,511,000 | 373,874,000 | 437,661,000 | 478,750,000 | 245,761,000 | 239,538,000 | 283,120,000 | 293,856,000 | 188,217,000 | 219,506,000 | 247,299,000 | 176,225,000 | 204,491,000 | 239,825,000 | 270,396,000 | 262,252,000 | 303,205,000 | 345,058,000 | 267,107,000 | 245,026,000 | 182,913,000 | 212,283,000 | 247,843,000 | 121,798,000 | 178,088,000 | 174,838,000 | 206,103,000 | 211,021,000 | 233,614,000 | 179,765,000 | 128,486,000 | 94,942,000 | 41,032,000 | 51,220,000 | 58,641,000 | 31,209,000 | 12,365,000 | 26,275,000 | 10,605 | 7,328,000 | 5,182,000 | 6,276,000 | 4,813,000 | 4,050,000 | 6,688,000 | 2,493,000 | 3,423 | 7,697,106 | 6,925,763 | 6,941,972 | 19,852,750 | 9,533,422 | 5,450,276 | 7,431,161 | 8,985,211 | 15,239,778 | 20,082,436 | 13,844,875 | 16,699,483 |
| accounts receivable | 130,694,000 | 75,360,000 | 27,342,000 | 12,596,000 | 42,000 | 909,000 | 1,190,000 | 4,467,000 | 221,000 | 7,000 | 93,000 | 35,000 | 5,050,000 | 313,000 | 54,000 | 7,500,000 | 94,000 | 233,000 | 1,701,000 | 2,115,000 | 19,000 | 883,000 | 104,000 | 803,000 | 6,812,000 | 1,838,000 | 3,818,000 | 5,789,000 | 5,446,000 | 1,286,000 | 853,000 | 1,000 | 1,074,000 | 1,907,000 | 381,000 | 1,981,000 | 2,189,000 | 1,153,000 | 1,743,000 | 2,851,000 | 1,536 | 1,981,000 | 3,193,000 | 2,266,000 | 1,569,000 | 1,500,000 | 1,914,000 | 1,715,000 | 1,418 | 3,369,388 | 1,084,929 | 2,613,580 | 60,991 | 706,360 | 795,680 | 998,456 | 1,155,950 | 2,504,698 | 697,237 | 846,173 | 1,237,480 | ||
| unbilled receivable | 3,026,000 | 1,717,000 | 1,249,000 | 1,531,000 | 696,000 | 1,874,000 | 3,643,000 | 2,345,000 | 5,405,000 | 11,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| non-cash royalty receivable | 8,514,000 | 9,249,000 | 8,115,000 | 7,236,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| inventory | 1,938,000 | 1,890,000 | 907,000 | 908,000 | 1,537,000 | 1,246,000 | 2,115,000 | 3,008,000 | 1,671,000 | 112,000 | 450,000 | 170,000 | 1,147,000 | 1,632,000 | 1,500,000 | 1,225,000 | 1,234,000 | 1,372,000 | 1,819,000 | 2,023,000 | 3,088,000 | 3,267 | 2,281,000 | 1,997,000 | 1,920,000 | 1,235,000 | 1,813,000 | 1,787,000 | 824,000 | 1,520 | 1,823,532 | 3,964,999 | 5,266,377 | 8,362,718 | 6,910,264 | 5,592,056 | 4,976,738 | 4,376,095 | 4,116,594 | 3,237,276 | 4,542,803 | 2,891,792 | |||||||||||||||||||||
| prepaid and other current assets | 18,712,000 | 14,089,000 | 10,955,000 | 11,005,000 | 16,714,000 | 14,099,000 | 8,807,000 | 7,322,000 | 14,330,000 | 14,504,000 | 15,421,000 | 7,901,000 | 7,875,000 | 6,426,000 | 7,653,000 | 5,425,000 | 4,961,000 | 6,649,000 | 6,710,000 | 4,462,000 | 6,320,000 | 9,893,000 | 4,881,000 | 7,334,000 | 6,618,000 | 4,080,000 | 1,795,000 | 2,321,000 | 3,140,000 | 1,622,000 | 1,976,000 | 2,419,000 | 1,279,000 | 1,356,000 | 1,126,000 | 1,715,000 | 1,161,000 | 973,000 | 508,000 | 2,463,000 | 2,509,000 | 1,571 | 1,611,000 | 1,097,000 | 1,114,000 | 1,298,000 | 1,467,000 | 954,000 | 1,002,000 | 1,398 | 567,170 | 672,185 | 636,510 | 913,032 | 526,045 | 583,711 | 1,124,291 | 1,341,467 | 2,724,833 | 2,075,666 | 1,864,899 | 2,141,077 | |
| total current assets | 766,900,000 | 669,273,000 | 243,864,000 | 304,121,000 | 330,416,000 | 393,924,000 | 456,718,000 | 499,999,000 | 270,887,000 | 274,397,000 | 319,572,000 | 324,254,000 | 219,327,000 | 241,371,000 | 270,726,000 | 208,898,000 | 225,681,000 | 259,378,000 | 289,835,000 | 278,781,000 | 322,714,000 | 364,618,000 | 254,780,000 | 193,304,000 | 223,246,000 | 262,016,000 | 128,330,000 | 189,458,000 | 187,736,000 | 215,707,000 | 217,058,000 | 238,821,000 | 183,609,000 | 135,923,000 | 102,235,000 | 48,006,000 | 58,533,000 | 65,953,000 | 51,749,000 | 59,394,000 | 66,688,000 | 72,054 | 76,046,000 | 78,488,000 | 80,678,000 | 84,544,000 | 92,974,000 | 94,452,000 | 96,260,000 | 99,936 | 103,501,685 | 105,115,516 | 108,203,232 | 116,082,691 | 114,024,330 | 116,201,138 | 117,167,482 | 128,369,784 | 136,999,259 | 150,727,677 | 158,701,572 | 159,764,717 | |
| property and equipment, net of accumulated depreciation | 4,431,000 | 3,776,000 | 4,067,000 | 4,377,000 | 4,474,000 | 4,334,000 | 4,431,000 | 4,663,000 | 4,636,000 | 4,957,000 | 5,417,000 | 5,760,000 | 5,578,000 | 5,902,000 | 6,018,000 | 6,993,000 | 9,118,000 | 10,052,000 | 13,720,000 | 12,891,000 | 13,209,000 | 12,029,000 | 22,704,000 | 22,404,000 | 21,518,000 | 18,510,000 | 14,668,000 | 10,753,000 | 10,173,000 | 10,561,000 | 11,352,000 | 11,442,000 | 12,805,000 | 14,825,000 | 15,494,000 | 17,081,000 | 18,081,000 | 19,039,000 | 22,183,000 | 16,495,000 | 8,586,000 | 8,149 | 8,624,000 | 8,837,000 | 9,121,000 | 9,319,000 | |||||||||||||||||
| operating lease right-of-use assets | 16,705,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| inventory, net of current portion | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| other assets | 14,159,000 | 14,300,000 | 14,496,000 | 14,011,000 | 13,100,000 | 12,676,000 | 8,672,000 | 8,711,000 | 8,535,000 | 8,886,000 | 7,325,000 | 10,986,000 | 8,570,000 | 7,591,000 | 6,831,000 | 3,784,000 | 3,413,000 | 1,850,000 | 3,665,000 | 3,709,000 | 3,941,000 | 4,437,000 | 3,430,000 | 2,925,000 | 2,942,000 | 911,000 | 108,000 | 400,000 | 203,000 | 183,000 | 196,000 | 174,000 | 141,000 | 189,000 | 162,000 | 226,000 | 36,000 | 42,000 | 32,000 | 12,000 | 12,000 | 218 | 218,000 | 406,000 | 218,000 | 265,000 | 265,000 | 265,000 | 265,000 | 313 | 312,946 | 312,946 | 312,946 | 333,700 | 333,700 | 333,700 | 333,700 | 333,700 | 333,700 | 43,700 | 43,700 | 43,700 | |
| total assets | 822,101,000 | 714,327,000 | 288,345,000 | 348,936,000 | 358,799,000 | 422,295,000 | 481,709,000 | 525,765,000 | 296,803,000 | 301,446,000 | 345,962,000 | 355,072,000 | 247,952,000 | 269,728,000 | 298,809,000 | 235,262,000 | 254,136,000 | 287,669,000 | 323,925,000 | 295,381,000 | 339,864,000 | 381,084,000 | 294,676,000 | 287,085,000 | 222,347,000 | 251,580,000 | 285,584,000 | 143,106,000 | 202,523,000 | 200,024,000 | 228,682,000 | 230,837,000 | 252,668,000 | 199,104,000 | 153,805,000 | 120,759,000 | 69,200,000 | 80,537,000 | 88,921,000 | 78,424,000 | 79,773,000 | 79,158,000 | 80,421 | 84,888,000 | 87,731,000 | 90,017,000 | 94,128,000 | 102,742,000 | 104,454,000 | 106,256,000 | 110,132 | 113,765,020 | 115,356,933 | 118,250,094 | 126,113,993 | 124,056,895 | 125,684,495 | 126,352,023 | 137,675,818 | 146,213,069 | 156,653,884 | 163,513,222 | 163,370,326 |
| liabilities and shareholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accounts payable | 24,853,000 | 18,441,000 | 32,260,000 | 45,353,000 | 20,178,000 | 17,245,000 | 16,060,000 | 18,434,000 | 10,520,000 | 11,631,000 | 12,916,000 | 9,538,000 | 8,913,000 | 12,739,000 | 9,534,000 | 9,933,000 | 7,227,000 | 7,809,000 | 8,777,000 | 11,365,000 | 10,352,000 | 12,881,000 | 11,510,000 | 10,100,000 | 13,404,000 | 9,689,000 | 4,957,000 | 3,812,000 | 3,122,000 | 2,723,000 | 4,706,000 | 3,216,000 | 2,850,000 | 1,769,000 | 1,092,000 | 1,280,000 | 1,981,000 | 1,051,000 | 1,720,000 | 2,168,000 | 1,892,000 | 2,226 | 2,202,000 | 1,093,000 | 1,869,000 | 1,346,000 | 1,477,000 | 940,000 | 1,352,000 | 2,099 | 3,278,550 | 1,673,579 | 1,598,984 | 2,473,991 | 1,231,337 | 1,282,398 | 2,725,212 | 979,571 | 573,442 | 2,183,612 | 1,461,188 | 860,290 | |
| accrued compensation | 15,155,000 | 10,734,000 | 11,780,000 | 11,111,000 | 8,621,000 | 4,960,000 | 3,408,000 | 5,469,000 | 4,718,000 | 3,599,000 | 2,882,000 | 4,620,000 | 3,942,000 | 4,321,000 | 5,211,000 | 8,991,000 | 13,232,000 | 19,564,000 | 4,423,000 | 11,796,000 | 10,316,000 | 8,524,000 | 10,724,000 | 6,589,000 | 5,455,000 | 3,262,000 | 3,712,000 | 4,162,000 | 3,276,000 | 5,063,000 | 3,173,000 | 2,436,000 | 2,306,000 | 2,461,000 | 1,837,000 | 3,228,000 | 2,181,000 | 1,727,000 | 1,481,000 | 2,355,000 | 1,357,000 | 1,213 | 2,770,000 | 2,321,000 | 1,146,000 | 925,000 | 1,946,000 | 2,019,000 | 1,027,000 | 728 | 2,584,289 | 1,698,700 | 1,308,141 | 1,943,632 | 1,155,953 | 924,946 | 528,051 | 348,805 | 457,249 | 1,686,335 | 1,216,130 | 1,080,248 | |
| other accrued liabilities | 43,571,000 | 36,292,000 | 30,918,000 | 38,783,000 | 47,136,000 | 36,588,000 | 28,730,000 | 23,077,000 | 34,718,000 | 29,185,000 | 32,820,000 | 29,320,000 | 21,114,000 | 15,363,000 | 18,916,000 | 13,932,000 | 14,040,000 | 14,681,000 | 20,629,000 | 20,465,000 | 24,117,000 | 17,865,000 | 9,713,000 | 9,150,000 | 7,718,000 | 9,631,000 | 6,844,000 | 6,158,000 | 6,904,000 | 6,337,000 | 4,467,000 | 7,421,000 | 3,236,000 | 2,495,000 | 2,253,000 | 2,429,000 | 2,665,000 | 2,284,000 | 3,064,000 | 2,133,000 | 2,024,000 | 4,476 | 4,259,000 | 3,983,000 | 3,470,000 | ||||||||||||||||||
| current portion of liability related to the sale of future royalties, net of deferred financing costs of 128 and 162, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of operating lease liability | 2,634,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of deferred revenue | 37,186,000 | 14,389,000 | 13,444,000 | 13,856,000 | 15,079,000 | 15,636,000 | 23,417,000 | 44,351,000 | 53,526,000 | 53,792,000 | 51,515,000 | 29,249,000 | 3,985,000 | 80,000 | 123,000 | 309,000 | 14,817,000 | 317,000 | 317,000 | 317,000 | 1,713,000 | 1,020,000 | 13,582,000 | 339,000 | 1,545,000 | 858,000 | 23,699,000 | 2,522,000 | 2,260,000 | 1,712,000 | 1,303,000 | 1,376,000 | 3,848,000 | 3,034,000 | 3,545,000 | 3,459,000 | 3,769,000 | 3,901,000 | 2,909,000 | 6,249,000 | 7,453,000 | 6,373 | 5,121,000 | 5,418,000 | 5,879,000 | 5,323,000 | 6,661,000 | 6,076,000 | 5,456,000 | 5,072 | 4,279,077 | 4,386,084 | 5,859,802 | 7,272,509 | 6,447,384 | 4,585,933 | 1,835,925 | 2,217,603 | 1,905,585 | 2,000,481 | 1,804,201 | 1,601,965 | |
| total current liabilities | 134,660,000 | 93,702,000 | 101,629,000 | 121,858,000 | 103,642,000 | 87,071,000 | 84,118,000 | 100,945,000 | 111,785,000 | 120,319,000 | 134,353,000 | 122,323,000 | 99,821,000 | 90,879,000 | 85,506,000 | 77,410,000 | 88,174,000 | 74,616,000 | 61,426,000 | 70,660,000 | 70,370,000 | 63,348,000 | 61,439,000 | 39,830,000 | 43,900,000 | 35,948,000 | 39,774,000 | 17,633,000 | 16,541,000 | 16,814,000 | 14,628,000 | 15,428,000 | 13,219,000 | 10,738,000 | 9,706,000 | 11,375,000 | 11,575,000 | 9,942,000 | 10,153,000 | 13,364,000 | 12,726,000 | 14,288 | 14,352,000 | 12,815,000 | 12,364,000 | 10,723,000 | 12,579,000 | 10,966,000 | 9,436,000 | 9,226 | 11,333,976 | 8,690,967 | 10,381,191 | 14,310,097 | 10,753,823 | 8,642,300 | 6,654,835 | 8,398,258 | 7,160,017 | 6,998,325 | 9,056,425 | 5,374,499 | |
| senior secured term loan | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| deferred revenue, net of current portion | 26,718,000 | 30,217,000 | 34,055,000 | 36,355,000 | 38,732,000 | 43,611,000 | 46,694,000 | 47,717,000 | 52,479,000 | 55,480,000 | 58,522,000 | 80,860,000 | 126,541,000 | 126,535,000 | 127,387,000 | 127,123,000 | 131,035,000 | 145,614,000 | 145,693,000 | 80,485,000 | 80,592,000 | 80,751,000 | 19,288,000 | 32,015,000 | 32,041,000 | 40,794,000 | 34,661,000 | 46,487,000 | 55,275,000 | 63,297,000 | 70,365,000 | 69,769,000 | 50,856,000 | 52,652,000 | 8,074,000 | 9,245,000 | 9,782,000 | 9,592,000 | 7,606,000 | 6,863,000 | 7,103,000 | 7,402 | 10,297,000 | 10,705,000 | 11,368,000 | 12,988,000 | 11,817,739 | 11,444,347 | |||||||||||||||
| operating lease liability, net of current portion | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liability related to the sale of future royalties, net of current portion and deferred financing costs of 111 and 205, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| other long-term liabilities | 2,800,000 | 300,000 | 300,000 | 300,000 | 300,000 | 466,000 | 676,000 | 1,306,000 | 2,079,000 | 2,442,000 | 2,480,000 | 2,586,000 | 2,818,000 | 2,587,000 | 1,489,000 | 707,000 | 970,000 | 1,943,000 | 473,000 | 4,180,000 | 4,193,000 | 4,231,000 | 4,192,000 | 4,173,000 | 4,171,000 | 4,127,000 | 3,796,000 | 3,230,000 | 3,385,000 | 3,698,000 | 3,733,000 | 3,799,000 | 3,919,000 | 4,165,000 | 4,141,000 | 3,822,000 | 3,810,000 | 3,737,000 | 3,029,000 | 1,237,000 | 1,268,000 | 330 | 297,000 | 286,000 | 371,000 | 350,000 | 374,000 | 365,000 | |||||||||||||||
| total liabilities | 260,505,000 | 223,485,000 | 166,427,000 | 193,110,000 | 180,792,000 | 172,464,000 | 175,241,000 | 200,179,000 | 219,710,000 | 232,981,000 | 251,842,000 | 265,502,000 | 290,843,000 | 294,251,000 | 302,912,000 | 311,383,000 | 340,361,000 | 355,843,000 | 351,529,000 | 284,409,000 | 292,976,000 | 291,894,000 | 369,389,000 | 263,490,000 | 268,266,000 | 273,975,000 | 84,135,000 | 72,487,000 | 80,583,000 | 89,680,000 | 94,842,000 | 95,356,000 | 75,333,000 | 75,628,000 | 30,238,000 | 33,249,000 | 34,218,000 | 32,567,000 | 31,062,000 | 26,636,000 | 21,097,000 | 22,020 | 23,087,000 | 22,819,000 | 23,032,000 | 21,778,000 | 24,321,000 | 24,319,000 | 23,285,000 | 23,290 | 24,359,318 | 22,865,020 | 23,604,558 | 29,492,805 | 26,797,634 | 27,182,366 | 16,585,499 | 18,741,242 | 18,141,752 | 18,826,070 | 20,506,772 | 16,339,897 | |
| commitments and contingencies | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| shareholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, .01 par value; authorized 5,000 shares; 22 and 0 shares issued and outstanding as of september 30, 2023 and december 31, 2022, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| common stock | 2,435,000 | 2,374,000 | 2,261,000 | 2,260,000 | 2,208,000 | 2,206,000 | 2,205,000 | 2,204,000 | 2,024,000 | 2,003,000 | 1,999,000 | 1,950,000 | 1,746,000 | 1,745,000 | 1,743,000 | 1,501,000 | 1,498,000 | 1,498,000 | 1,494,000 | 1,494,000 | 1,490,000 | 1,490,000 | 872,000 | 871,000 | 870,000 | 870,000 | 859,000 | 856,000 | 853,000 | 844,000 | 842,000 | 841,000 | 764,000 | 680,000 | 680,000 | 574,000 | 573,000 | 571,000 | 508,000 | 429,000 | 425,000 | 423 | 422,000 | 416,000 | 452,000 | 451,000 | 451,000 | 448,000 | 448,000 | 447 | 446,809 | 445,021 | 444,649 | 443,763 | 442,913 | 442,648 | 442,572 | 442,554 | 400,201 | 397,689 | 396,854 | ||
| additional paid-in capital | 2,267,747,000 | 2,227,802,000 | 1,854,743,000 | 1,847,638,000 | 1,810,863,000 | 1,804,934,000 | 1,799,551,000 | 1,794,525,000 | 1,509,040,000 | 1,463,094,000 | 1,458,012,000 | 1,419,460,000 | 1,318,591,000 | 1,314,586,000 | 1,310,710,000 | 1,209,846,000 | 1,204,559,000 | 1,200,860,000 | 1,197,988,000 | 1,192,813,000 | 1,186,934,000 | 1,182,429,000 | 770,511,000 | 765,751,000 | 758,281,000 | 753,349,000 | 728,525,000 | 713,361,000 | 706,581,000 | 693,050,000 | 688,694,000 | 685,619,000 | 573,127,000 | 476,981,000 | 475,092,000 | 394,100,000 | 392,433,000 | 389,565,000 | 345,868,000 | 317,696,000 | 316,335,000 | 315 | 314,452,000 | 312,462,000 | 322,494,000 | 321,885,000 | 321,187,000 | 319,766,000 | 319,140,000 | 318,300 | 318,255,236 | 317,848,497 | 317,708,580 | 317,283,894 | 317,149,342 | 317,048,421 | 317,045,447 | 317,034,138 | 317,025,491 | 316,672,814 | 314,472,119 | ||
| accumulated deficit | -1,708,586,000 | -1,739,334,000 | -1,735,086,000 | -1,694,072,000 | -1,635,064,000 | -1,557,309,000 | -1,495,288,000 | -1,471,143,000 | -1,433,971,000 | -1,396,632,000 | -1,365,891,000 | -1,331,840,000 | -1,363,228,000 | -1,340,854,000 | -1,316,556,000 | -1,287,468,000 | -1,292,282,000 | -1,270,532,000 | -1,227,086,000 | -1,183,335,000 | -1,141,536,000 | -1,094,729,000 | -853,687,000 | -244,814,000 | -238,561,000 | -231,916,000 | -228,935,000 | -225,433,000 | |||||||||||||||||||||||||||||||||||
| total shareholders’ equity | 561,596,000 | 490,842,000 | 121,918,000 | 155,826,000 | 178,007,000 | 249,831,000 | 306,468,000 | 325,586,000 | 77,093,000 | 68,465,000 | 94,120,000 | 89,570,000 | 10,972,000 | 46,888,000 | 89,190,000 | 11,609,000 | 58,971,000 | 130,036,000 | 119,441,000 | 139,002,000 | 135,995,000 | 157,312,000 | 123,771,000 | 78,177,000 | 90,521,000 | 35,951,000 | 46,319,000 | 56,354,000 | 53,137,000 | 58,061,000 | |||||||||||||||||||||||||||||||||
| total liabilities and shareholders’ equity | 822,101,000 | 714,327,000 | 288,345,000 | 348,936,000 | 358,799,000 | 422,295,000 | 481,709,000 | 525,765,000 | 296,803,000 | 301,446,000 | 345,962,000 | 355,072,000 | 295,381,000 | 339,864,000 | 381,084,000 | 222,347,000 | 251,580,000 | 285,584,000 | 143,106,000 | 202,523,000 | 200,024,000 | 228,682,000 | 230,837,000 | 252,668,000 | 199,104,000 | 153,805,000 | 120,759,000 | 69,200,000 | 80,537,000 | 88,921,000 | 79,773,000 | 79,158,000 | |||||||||||||||||||||||||||||||
| current portion of liability related to the sale of future royalties, net of deferred financing costs of 143 and 162, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liability related to the sale of future royalties, net of current portion and deferred financing costs of 136 and 205, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, .01 par value; authorized 5,000 shares; 22 and 0 shares issued and outstanding as of june 30, 2023 and december 31, 2022, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of liability related to the sale of future royalties, net of deferred financing costs of 150 and 162, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liability related to the sale of future royalties, net of current portion and deferred financing costs of 172 and 205, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, .01 par value; authorized 5,000 shares; no shares issued and outstanding as of march 31, 2023 and december 31, 2022, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| contract assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of liability related to the sale of future royalties, net of deferred financing costs of 162 and 198, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liability related to the sale of future royalties, net of current portion and deferred financing costs of 205 and 381, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, .01 par value; authorized 5,000 shares; no shares issued and outstanding as of each of december 31, 2022 and 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of liability related to the sale of future royalties, net of deferred financing costs of 175 and 198, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liability related to the sale of future royalties, net of current portion and deferred financing costs of 241 and 381, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, .01 par value; authorized 5,000 shares; no shares issued and outstanding as of each of september 30, 2022 and december 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of liability related to the sale of future royalties, net of deferred financing costs of 187 and 198, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liability related to the sale of future royalties, net of current portion and deferred financing costs of 282 and 381, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, .01 par value; authorized 5,000 shares; no shares issued and outstanding as of each of june 30, 2022 and december 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of liability related to the sale of future royalties, net of deferred financing costs of 199 and 198, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liability related to the sale of future royalties, net of current portion and deferred financing costs of 323 and 381, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, .01 par value; authorized 5,000 shares; no shares issued and outstanding as of each of march 31, 2022 and december 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible 4.5% senior notes, net of deferred financing costs of 0 and 7, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of liability related to the sale of future royalties, net of deferred financing costs of 198 and 319, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liability related to the sale of future royalties, net of current portion and deferred financing costs of 381 and 584, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, .01 par value; authorized 5,000 shares; no shares issued and outstanding as of each of december 31, 2021 and december 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| unbilled receivables | 4,706,000 | 4,227,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of liability related to the sale of future royalties, net of deferred financing costs of 206 and 319, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liability related to the sale of future royalties, net of current portion and deferred financing costs of 427 and 584, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, .01 par value; authorized 5,000 shares; no shares issued and outstanding as of each of september 30, 2021 and december 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of liability related to the sale of future royalties, net of deferred financing costs of 231 and 319, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liability related to the sale of future royalties, net of current portion and deferred financing costs of 473 and 584, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, .01 par value; authorized 5,000 shares; no shares issued and outstanding as of each of june 30, 2021 and december 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible 4.5% senior notes, net of deferred financing costs of 4 and 7, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of liability related to the sale of future royalties, net of deferred financing costs of 267 and 319, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liability related to the sale of future royalties, net of current portion and deferred financing costs of 525 and 584, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| shareholders’ deficit: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, .01 par value; authorized 5,000 shares; no shares issued and outstanding as of each of march 31, 2021 and december 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible 4.5% senior notes, net of deferred financing costs of 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of liability related to the sale of future royalties, net of deferred financing costs of 319 and 635, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible 4.5% senior notes, net of deferred financing costs of 22 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liability related to the sale of future royalties, net of current portion and deferred financing costs of 584 and 859, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, .01 par value; authorized 5,000 shares; no shares issued and outstanding as of december 31, 2020 and december 31, 2019, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| unbilled revenue/reimbursement | 5,000 | 5,000 | 1,753,000 | 1,001,000 | 3,009,000 | 2,474,000 | 3,982,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liabilities and shareholders’ deficit | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible 4.5% senior notes, net of deferred financing costs of 11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of liability related to the sale of future royalties, net of deferred financing costs of 402 and 635, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liability related to the sale of future royalties, net of current portion and deferred financing costs of 625 and 859, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, .01 par value; authorized 5,000 shares; no shares issued and outstanding as of september 30, 2020 and december 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total shareholders’ deficit | -42,891,000 | -24,523,000 | -4,103,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total liabilities and shareholders’ deficit | 247,952,000 | 269,728,000 | 298,809,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of liability related to the sale of future royalties, net of deferred financing costs of 470 and 635, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible 4.5% senior notes, net of deferred financing costs of 15 and 22, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liability related to the sale of future royalties, net of current portion and deferred financing costs of 699 and 859, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, .01 par value; authorized 5,000 shares; no shares issued and outstanding as of june 30, 2020 and december 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of liability related to the sale of future royalties, net of deferred financing costs of 557 and 635, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible 4.5% senior notes, net of deferred financing costs of 18 and 22, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liability related to the sale of future royalties, net of current portion and deferred financing costs of 765 and 859, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, .01 par value; authorized 5,000 shares; no shares issued and outstanding as of march 31, 2020 and december 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| contract asset | 500,000 | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liabilities and shareholders’ (deficit) equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of deferred lease incentive | 837,000 | 832,000 | 793,000 | 772,000 | 651,000 | 646,000 | 646,000 | 562,000 | 979,000 | 979,000 | 979,000 | 979,000 | 979,000 | 979,000 | 979,000 | 979,000 | 979,000 | 979,000 | 979,000 | 979,000 | |||||||||||||||||||||||||||||||||||||||||||
| current portion of liability related to the sale of future royalties, net of deferred financing costs of 635 and 753, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| deferred lease incentive, net of current portion | 4,675,000 | 4,854,000 | 4,806,000 | 6,236,000 | 5,836,000 | 5,978,000 | 6,139,000 | 5,904,000 | 5,137,000 | 5,382,000 | 5,871,000 | 6,116,000 | 6,360,000 | 7,339,000 | 8,073,000 | 8,317,000 | 8,807,000 | 9,051,000 | 9,296,000 | 10,274,000 | |||||||||||||||||||||||||||||||||||||||||||
| operating lease liability - net of current portion | 24,084,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible 4.5% senior notes, net of deferred financing costs of 22 and 36, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liability related to the sale of future royalties, net of current portion and deferred financing costs of 859 and 1,536, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, .01 par value; authorized 5,000 shares; no shares issued and outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total shareholders’ (deficit) equity | -76,121,000 | -86,225,000 | -68,174,000 | -27,604,000 | -82,304,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total liabilities and shareholders’ (deficit) equity | 235,262,000 | 254,136,000 | 287,669,000 | 323,925,000 | 287,085,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of liability related to the sale of future royalties, net of deferred financing costs of 707 and 753, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible 4.5% senior notes, net of deferred financing costs of 25 and 36, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liability related to the sale of future royalties, net of current portion and deferred financing costs of 977 and 1,536, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of liability related to the sale of future royalties, net of deferred financing costs of 715 and 753, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible 4.5% senior notes, net of deferred financing costs of 29 and 36, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liability related to the sale of future royalties, net of current portion and deferred financing costs of 1,175 and 1,536, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of liability related to the sale of future royalties, net of deferred financing costs of 590 and 753, respectively | 24,646,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible 4.5% senior notes, net of deferred financing costs of 32 and 36, respectively | 2,068,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liability related to the sale of future royalties, net of current portion and deferred financing costs of 1,500 and 1,536, respectively | 117,785,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| unbilled revenue | 617,000 | 521,000 | 522,000 | 1,409,000 | 1,027,000 | 885,000 | 899,000 | 784,000 | 1,904,000 | 1,979,000 | 2,105,000 | 2,006,000 | 1,446,000 | 1,098,000 | 2,356,000 | 1,741,000 | 1,894,000 | 1,150,000 | 975,000 | 3,351,000 | 4,239,000 | 4,369,000 | 5,980 | 6,150,000 | 5,519,000 | 5,102,000 | 5,419,000 | 5,429,000 | 4,797,000 | 5,895,000 | 5,035 | 6,171,548 | 6,057,787 | 4,666,436 | 4,955,562 | 5,206,970 | 1,887,276 | 267,020 | 628,372 | 470,958 | 715,504 | ||||||||||||||||||||||
| current portion of liability related to the sale of future royalties, net of deferred financing costs of 753 and 772, respectively | 25,880,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible 4.5% senior notes, net of deferred financing costs of 36 and 50, respectively | 2,064,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liability related to the sale of future royalties, net of current portion and deferred financing costs of 1,536 and 2,373, respectively | 122,345,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of liability related to the sale of future royalties, net of deferred financing costs of 759 and 772, respectively | 23,040,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible 4.5% senior notes, net of deferred financing costs of 40 and 50, respectively | 2,060,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liability related to the sale of future royalties, net of current portion and deferred financing costs of 1,739 and 2,373, respectively | 130,907,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of liability related to the sale of future royalties, net of deferred financing costs of 788 and 772, respectively | 22,265,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible 4.5% senior notes, net of deferred financing costs of 43 and 50, respectively | 2,057,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liability related to the sale of future royalties, net of current portion and deferred financing costs of 1,918 and 2,373, respectively | 136,701,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| consolidated statement of operations data: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total revenues | 115,447,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total operating expenses | 174,429,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| non-cash interest expense on liability related to sale of future royalty and convertible senior notes | 13,682,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| non-cash debt conversion expense | 22,915,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| other income | -433,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net income | -96,012,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic and diluted net income per common share | -980 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic and diluted weighted-average common shares outstanding | 98,068,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| consolidated balance sheet data: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| long-term convertible notes - net | 2,050,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| shareholders’ (deficit) equity | -17,895,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of deferred financing costs | 1,674,000 | 1,018,000 | 1,120,000 | 1,136,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| deferred financing costs, net of current portion | 6,171,000 | 3,714,000 | 3,874,000 | 4,147,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of liability related to the sale of future royalties | 15,138,000 | 13,001,000 | 15,132,000 | 11,862,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| convertible 4.5% senior notes | 100,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liability related to the sale of future royalties, net of current portion | 178,234,000 | 181,636,000 | 182,176,000 | 186,967,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| shareholders’ (deficit) equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.01 par value; authorized 5,000 shares; no shares issued and outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| restricted cash | 319,000 | 319,000 | 319,000 | 319,000 | 319,000 | 319,000 | 1,019,000 | 1,019,000 | 574,000 | 574,000 | 574,000 | 366,000 | 268,000 | 268,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| long-term restricted cash | 1,912,000 | 1,912,000 | 2,231,000 | 2,231,000 | 2,231,000 | 2,549,000 | 2,868,000 | 2,868,000 | 3,887,000 | 3,887,000 | 3,887,000 | 4,460,000 | 3,872,000 | 3,872,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| marketable securities | 1,185,000 | 1,213,000 | 1,229,000 | 13,343,000 | 36,293,000 | 27,328,000 | 49,095 | 56,695,000 | 61,500,000 | 64,000,000 | 70,210,000 | 78,715,000 | 78,312,000 | 84,331,000 | 87,142 | 83,872,941 | 86,409,853 | 88,078,357 | 81,937,638 | 91,141,269 | 101,892,139 | 102,369,816 | 111,882,689 | 111,942,398 | 123,919,558 | 137,223,913 | 135,732,305 | ||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive income | 235,000 | 147,000 | 44,000 | 72,861 | 56,200 | 67,645 | 208,123 | 500,132 | 823,984 | 199,049 | 708,024 | 1,254,778 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| liabilities and stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| stockholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive loss | -76,000 | -354,000 | -230,000 | -73,000 | -113,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total stockholders’ equity | 47,362,000 | 58,401 | 61,801,000 | 64,912,000 | 66,985,000 | 72,350,000 | 78,421,000 | 80,135,000 | 82,971,000 | 86,842 | 89,405,702 | 92,491,913 | 94,645,536 | 96,621,188 | 97,259,261 | 98,502,129 | 109,766,524 | 118,934,576 | 128,071,317 | 137,827,814 | 143,006,450 | 147,030,429 | |||||||||||||||||||||||||||||||||||||||||
| total liabilities and stockholders’ equity | 78,424,000 | 80,421 | 84,888,000 | 87,731,000 | 90,017,000 | 94,128,000 | 102,742,000 | 104,454,000 | 106,256,000 | 110,132 | 113,765,020 | 115,356,933 | 118,250,094 | 126,113,993 | 124,056,895 | 125,684,495 | 126,352,023 | 137,675,818 | 146,213,069 | 156,653,884 | 163,513,222 | 163,370,326 | |||||||||||||||||||||||||||||||||||||||||
| current portion of lease incentive obligation | 459,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| lease incentive obligation, net of current portion | 5,172,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| long-term portion deferred revenue | 8,438,000 | 9,718,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| treasury stock | -11,071,000 | -11,071,000 | -11,071,000 | -11,071,000 | -11,071,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| other current accrued liabilities | 3,129,000 | 2,495,000 | 1,931,000 | 1,601,000 | 1,327 | 1,192,060 | 932,604 | 1,614,264 | 2,619,965 | 1,919,149 | 1,849,023 | 1,565,647 | 4,852,279 | 4,223,741 | 1,127,897 | 4,572,086 | 1,826,466 | ||||||||||||||||||||||||||||||||||||||||||||||
| deferred compensation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| property and equipment | 9,503,000 | 9,737,000 | 9,731,000 | 9,883 | 9,950,389 | 9,928,471 | 9,733,916 | 9,697,602 | 9,698,865 | 9,149,657 | 8,750,110 | 8,158,890 | 7,030,110 | 5,882,507 | 4,767,950 | 3,561,909 | |||||||||||||||||||||||||||||||||||||||||||||||
| deferred revenue | 13,430,000 | 13,739 | 12,723,967 | 13,750,860 | 12,930,531 | 14,956,540 | 15,969,543 | 18,482,552 | 9,908,536 | 10,321,527 | 10,965,580 | 10,965,398 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| other long term liabilities | 419,000 | 325 | 301,375 | 423,193 | 292,836 | 226,168 | 74,268 | 57,514 | 22,128 | 21,457 | 16,155 | 10,006 | 6,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| deposit on construction in progress | 100,731 | 813,444 | 1,850,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| shares and 40,155,560 shares as of september 30, 2002 and june 30, 2002, respectively | 442,539 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| long term marketable securities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| current portion of capital lease obligations | 2,820 | 5,530 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| earned and unbilled revenue | 378,909 | 1,062,580 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| liabilities and stockholders' equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| stockholders' equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| additional paid–in capital | 316,217,927 |
We provide you with 20 years of balance sheets for ImmunoGen stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ImmunoGen. Explore the full financial landscape of ImmunoGen stock with our expertly curated balance sheets.
The information provided in this report about ImmunoGen stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.